ArticleBritish journal of pharmacology2010

Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis.

P H Schafer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.